← Back to Analyst Consensus 
MMSI Buy
MERIT MEDICAL SYSTEMS INC
Current Price —
Implied Upside —
Analysts 17
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Oct 29, 2026 (3 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 29, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| Aug 13, 2026 | B of A Securities | maintain | Neutral → Neutral | — | 53% |
| Aug 11, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Aug 3, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Jul 31, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| Jul 31, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Jul 31, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Jul 31, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Jul 31, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| May 1, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| May 1, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| May 1, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| May 1, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Apr 20, 2026 | Barrington Research | maintain | Outperform → Outperform | — | 56% |
| Apr 17, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Apr 7, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Apr 1, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| Feb 26, 2026 | Wells Fargo | downgrade | Overweight → Equal-Weight | $78 | 54% |
| Feb 25, 2026 | Barrington Research | maintain | Outperform → Outperform | $109 | 56% |
| Feb 25, 2026 | Needham | maintain | Buy → Buy | $101 | 50% |
| Feb 18, 2026 | Piper Sandler | maintain | Overweight → Overweight | $106 | 54% |
| Feb 6, 2026 | BTIG | initiate | — → Buy | $107 | 52% |
| Jan 9, 2026 | Needham | reiterate | Buy → Buy | $108 | 50% |
| Dec 17, 2025 | Canaccord Genuity | maintain | Buy → Buy | $99 | 48% |
| Nov 14, 2025 | Barrington Research | maintain | Outperform → Outperform | $106 | 56% |
| Nov 14, 2025 | Canaccord Genuity | maintain | Buy → Buy | $93 | 48% |
| Nov 14, 2025 | Wells Fargo | maintain | Overweight → Overweight | $95 | 54% |
| Oct 31, 2025 | Barrington Research | maintain | Outperform → Outperform | $106 | 56% |
| Oct 31, 2025 | Piper Sandler | reiterate | Overweight → Overweight | $109 | 54% |
| Oct 31, 2025 | Needham | reiterate | Buy → Buy | $108 | 50% |
| Oct 16, 2025 | Canaccord Genuity | maintain | Buy → Buy | $104 | 48% |
| Oct 7, 2025 | Barrington Research | maintain | Outperform → Outperform | $103 | 56% |
| Sep 23, 2025 | Barrington Research | maintain | Outperform → Outperform | $103 | 56% |
| Jul 31, 2025 | Wells Fargo | maintain | Overweight → Overweight | $100 | 54% |
| Jul 31, 2025 | Raymond James | maintain | Outperform → Outperform | $102 | 54% |
| Jul 31, 2025 | Piper Sandler | maintain | Overweight → Overweight | $105 | 54% |
| Jul 31, 2025 | Barrington Research | maintain | Outperform → Outperform | $103 | 56% |
| Jul 18, 2025 | Needham | reiterate | Buy → Buy | $108 | 50% |
| Jul 8, 2025 | Needham | reiterate | Buy → Buy | $108 | 50% |
| May 23, 2025 | Piper Sandler | maintain | Overweight → Overweight | $110 | 54% |
| May 21, 2025 | Canaccord Genuity | maintain | Buy → Buy | $112 | 48% |
| May 21, 2025 | Wells Fargo | maintain | Overweight → Overweight | $108 | 54% |
| May 20, 2025 | Needham | reiterate | Buy → Buy | $108 | 50% |
| May 15, 2025 | Needham | maintain | Buy → Buy | $108 | 50% |
| Apr 25, 2025 | Canaccord Genuity | maintain | Buy → Buy | $108 | 48% |
| Apr 25, 2025 | Piper Sandler | maintain | Overweight → Overweight | $106 | 54% |
| Apr 25, 2025 | Raymond James | maintain | Outperform → Outperform | $108 | 54% |
| Apr 25, 2025 | Barrington Research | maintain | Outperform → Outperform | $103 | 56% |
| Apr 25, 2025 | Needham | maintain | Buy → Buy | $100 | 50% |
| Apr 25, 2025 | Baird | maintain | Outperform → Outperform | $110 | 55% |
Price Target Trend
Apr 25, 2026 Latest: $101.64 Oct 24, 2026
EPS Estimates
+1q $1.14
Lo: $1.11 Hi: $1.15
10 analysts ▲4
0y $4.30
Lo: $4.28 Hi: $4.32
10 analysts ▲8
0q $1.03
Lo: $1.01 Hi: $1.05
10 analysts ▲5
+1y $4.61
Lo: $4.50 Hi: $4.77
10 analysts ▲9
Cross-Platform Signals
No cross-platform signals in the last 90 days